Study reveals sex-specific effects of prenatal cannabinoid exposure on adult offspring and identifies potential new therapeutic strategies.
A2LA will now work with ATACH to promote open-source quality management standards for the cannabis and hemp industries.
Experts say that Canadian parents use unregulated cannabinoids for seizure control in children with neurologic conditions like epilepsy, and clinical trials are needed to inform doctors and parents on prescribing.
Failing to comply with the standards in place puts a cannabis company at risk of litigation and jeopardizes business contracts with other downstream cannabis operators.
Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.
New study finds that a single dose of cannabidiol in rats with symptoms of depression is highly effective, eliminating the symptoms on the same day and maintaining the beneficial effects for a week.
Research from King’s College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psychosis.
Researchers at the Center for BrainHealth® at the University of Texas at Dallas investigated the effects on the brain of concurrent cannabis and nicotine use, versus the use of solely cannabis and solely nicotine.
Scientists have found the primary psychoactive component of marijuana in 63% of breast milk samples for up to six days after the mother’s last reported use.